Valuation: Navamedic ASA

Market Cap 324M 33.64M 29.88M 27.95M 25.47M 47.94M 3.24B 48.6M 338M 131M 1.65B 126M 124M 5.3B P/E 2026 *
-50.3x
P/E 2027 * 43.2x
Enterprise Value 443M 46.06M 40.91M 38.26M 34.87M 65.64M 4.44B 66.54M 463M 179M 2.26B 173M 169M 7.25B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.7x
Free-Float
30.5%
Yield 2026 *
-
Yield 2027 * -
1 day-1.82%
1 week+1.12%
Current month-1.82%
1 month-4.59%
3 months-17.43%
6 months-31.82%
Current year-43.28%
1 week 13.05
Extreme 13.05
13.9
1 month 13.05
Extreme 13.05
14.3
Current year 13.05
Extreme 13.05
24.5
1 year 13.05
Extreme 13.05
26.5
3 years 13.05
Extreme 13.05
43.9
5 years 13.05
Extreme 13.05
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 55 18/06/2026
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 60 01/06/2024
Chairman 66 -
Director/Board Member 68 23/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/24 Buy

Chief Operating Officer

10,267 0.0581%
9/9/24 Exercice

Chief Executive Officer

80,000 0.4589%
9/9/24 Exercice

Chief Operating Officer

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%+1.12%-37.21%-65.65% 34.38M
-0.62%-0.10%+50.70%+114.07% 1,031B
-2.30%-3.90%+39.50%+66.07% 638B
-0.63%-1.94%+12.26%+74.38% 462B
-1.03%-2.88%+71.35%+39.69% 359B
-0.03%-3.91%+34.28%+39.35% 335B
-1.58%+0.39%+17.92%+25.77% 273B
-2.02%-3.20%+7.60%+8.38% 253B
-3.38%+0.29%+44.32%+51.54% 228B
-1.04%-2.56%+32.88%+96.82% 185B
Average -1.38%-0.03%+27.36%+45.04% 376.39B
Weighted average by Cap. -1.12%-0.35%+38.05%+69.18%

Financials

2026 *2027 *
Net sales 570M 59.22M 52.6M 49.19M 44.82M 84.39M 5.7B 85.55M 595M 230M 2.9B 222M 218M 9.33B 604M 62.76M 55.75M 52.13M 47.51M 89.44M 6.04B 90.67M 631M 244M 3.08B 236M 231M 9.88B
Net income -6.5M -675K -600K -561K -511K -962K -65M -975K -6.78M -2.63M -33.1M -2.53M -2.48M -106M 7.7M 800K 711K 664K 606K 1.14M 77.02M 1.16M 8.04M 3.11M 39.23M 3M 2.94M 126M
Net Debt 120M 12.42M 11.03M 10.32M 9.4M 17.7M 1.2B 17.94M 125M 48.31M 609M 46.63M 45.62M 1.96B 96.9M 10.07M 8.94M 8.36M 7.62M 14.35M 970M 14.55M 101M 39.17M 494M 37.81M 36.99M 1.59B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
01/10/26 NOK 13.50 -1.82% 5,321
30/09/26 NOK 13.75 +1.10% 11,906
29/09/26 NOK 13.60 +2.26% 9,441
28/09/26 NOK 13.30 -0.37% 14,669
25/09/26 NOK 13.35 0.00% 11,273
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.50NOK
Average target price
21.00NOK
Spread / Average Target
+55.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock